Enhanced chemoimmunotherapy of breast cancer in mice by apolipoprotein A1-modified doxorubicin liposomes combined with interleukin-21
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced chemoimmunotherapy of breast cancer in mice by apolipoprotein A1-modified doxorubicin liposomes combined with interleukin-21
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2023-11-01
DOI
10.1080/1061186x.2023.2276664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells
- (2022) Ceyhan Hacioglu et al. METABOLIC BRAIN DISEASE
- Tumor-associated neutrophils and neutrophil-targeted cancer therapies
- (2022) Haiying Que et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
- (2022) Yanyan Xu et al. Acta Pharmaceutica Sinica B
- APOA1: a Protein with Multiple Therapeutic Functions
- (2021) Blake J. Cochran et al. Current Atherosclerosis Reports
- Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
- (2021) Duopeng An et al. MOLECULES
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects
- (2021) Alessandro Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond
- (2021) Alessandro Rizzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells
- (2020) Márcia Cristina Oliveira da Rocha et al. JOURNAL OF NANOBIOTECHNOLOGY
- Citrinin exposure disrupts organelle distribution and functions in mouse oocytes
- (2020) Ming-Hong Sun et al. ENVIRONMENTAL RESEARCH
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- Combining conventional therapy with immunotherapy: A risky business?
- (2019) A. Coosemans et al. EUROPEAN JOURNAL OF CANCER
- The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
- (2019) Warren J. Leonard et al. IMMUNITY
- Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
- (2019) Wei-Di Yu et al. CANCER LETTERS
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing
- (2019) Isabel Prager et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
- (2018) Xuyao Zhang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
- (2018) Xuyao Zhang et al. CARCINOGENESIS
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
- (2018) Tao Shi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within
- (2018) Sarina Kajani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
- (2018) Eric M. Mastria et al. JOURNAL OF CONTROLLED RELEASE
- IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I–Deficient Tumors
- (2018) Hyungseok Seo et al. Cancer Immunology Research
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma
- (2018) Tong-Fei Li et al. BIOMATERIALS
- Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis
- (2018) Xuyao Zhang et al. Nanoscale
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up
- (2018) Sylvia Adams et al. JAMA Oncology
- Tumor Microenvironment and Differential Responses to Therapy
- (2017) Eishu Hirata et al. Cold Spring Harbor Perspectives in Medicine
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
- (2017) Xuyao Zhang et al. Cancer Immunology Research
- IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
- (2016) Elizabeth L. McMichael et al. CLINICAL CANCER RESEARCH
- Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells
- (2016) Fangrong Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis
- (2016) Alice Valentin-Torres et al. Journal of Neuroinflammation
- Interleukin 21 – its potential role in the therapy of B-cell lymphomas
- (2016) Shruti Bhatt et al. LEUKEMIA & LYMPHOMA
- Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
- (2016) Linda K. Mooberry et al. Frontiers in Pharmacology
- Cancer immunotherapy: Strategies for personalization and combinatorial approaches
- (2015) Vishwanath Sathyanarayanan et al. Molecular Oncology
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Dok1 and Dok2 proteins regulate natural killer cell development and function
- (2014) Javier Celis‐Gutierrez et al. EMBO JOURNAL
- Human Peripheral Neutrophils Express Functional IL-21 Receptors
- (2014) Yuji Takeda et al. INFLAMMATION
- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells
- (2013) Saskia JAM Santegoets et al. Journal of Translational Medicine
- Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria
- (2013) Nana O. Wilson et al. PLoS One
- Mechanisms and management of doxorubicin cardiotoxicity
- (2011) Y. Shi et al. HERZ
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now